RECURIUM EQUITY, LLC enters ZENTALIS PHARMACEUTICALS, INC. with 4.16M shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 4/3/2020ACC: 0000899243-20-010232
10% Owner
Since Apr 2020
4.16M
Baseline shares
100% direct
4.16M
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned4.16M
Total
4.16M direct4.16M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.16M | Direct |
| Total | 4.16M | 4.16M direct |
Derivative Holdings0
No derivative holdings reported